Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial

BACKGROUND: Antipsychotic-induced Weight Gain (AiWG) is a debilitating and common adverse effect of antipsychotics. AiWG negatively impacts life expectancy, quality of life, treatment adherence, likelihood of developing type-2 diabetes and readmission. Treatment of AiWG is currently challenging, and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Psychiatry
Main Authors: de Boer, Nini, Guloksuz, Sinan, van Baal, Caroline, Willebrands, Leonie, Deenik, Jeroen, Vinkers, Christiaan H., Rossum, Inge Winter-van, Zinkstok, Janneke, Wilting, Ingeborg, Zantvoord, Jasper B., Backx, Frank, Swildens, Wilma E., Schouw, Marieke, Bogers, Jan, Hulshof, Folkwin, de Knijff, Rudolf, Duindam, Peter, Veereschild, Mike, Bak, Maarten, Frederix, Geert, de Haan, Lieuwe, van Os, Jim, Cahn, Wiepke, Luykx, Jurjen J.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783702/
https://ncbi.nlm.nih.gov/pubmed/33402159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-020-02992-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados